[Federal Register Volume 86, Number 24 (Monday, February 8, 2021)]
[Notices]
[Pages 8645-8646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02550]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-21-1054]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled, ``Drug Overdose Response Investigation 
(DORI) Data Collections'' to the Office of Management and Budget (OMB) 
for review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
August 13,2020 to obtain comments from the public and affected 
agencies. CDC did not receive comments related to the previous notice. 
This notice serves to allow an additional 30 days for public and 
affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Drug Overdose Response Investigation (DORI) Data Collections (OMB 
Control No. 0920-1054, Exp. 03/31/2021)--Extension--National Center for 
Injury Prevention and Control (NCIPC), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    In 2015, CDC received OMB approval (OMB Control No. 0920-1054) for 
this Generic clearance for a three-year period to collect information 
to response to urgent requests from state and local health authorities 
to provide epidemiological information that allows for the selection of 
interventions to curb local epidemics of drug overdose. CDC seeks OMB 
approval for an Extension of this Generic clearance for a three-year 
period.
    Drug Overdose Response Investigations (DORI) are to be conducted in 
response to urgent requests from state and local health authorities to 
provide epidemiological information that allows for the selection of 
interventions to curb local epidemics of drug overdose. Of particular 
interest is response to increasing trends in, or changing 
characteristics of, overdose from prescription drugs (with a special 
interest in opioid analgesics such as oxycodone or methadone; 
benzodiazepines such as alprazolam) and/or illicit drugs (e.g., 
heroin). CDC's National Center for Injury Prevention and Control 
(NCIPC) is frequently called upon to conduct DORIs at the request of 
state or local health authorities seeking support to respond to urgent 
public health problems resulting from drug use, misuse, addiction, and 
overdose. Such requests are typically, but not always, made through the 
Epi-Aid mechanism; in most investigations, CDC's epidemiological 
response entails rapid and flexible collection of data that evolves 
during the investigation period.
    Generic clearance is requested to ensure that timely information is 
collected during a DORI, which allows NCIPC to maintain critical 
mission function by working with state and local health authorities to 
protect the public's health. During an unanticipated rise in nonfatal 
or fatal drug overdose where the substances responsible for the health 
event need to be identified, drivers and risk factors are undetermined, 
and/or subgroups at risk need to be identified, immediate action by CDC 
is necessary to minimize or prevent public harm. CDC must have the 
ability to rapidly deploy data collection tools to understand the scope 
of the problem and determine appropriate action. Procedures for each 
investigation, including specific data collection plans, depend on the 
time and resources available, number of persons involved, and other 
circumstances unique to the urgent conditions at hand. Data are 
collected by epidemiologists, psychologists, medical professionals, 
subject matter experts, and biostatisticians.
    Data collected during a DORI are used to understand sudden 
increases in drug use and misuse associated with fatal and nonfatal 
overdoses, understand the drivers and risk factors associated with 
those trends, and identify the groups most affected. This allows CDC to 
effectively advise states on actions that could be taken to control the 
local epidemic. During a DORI, data are collected once, with the rare 
need for follow-up. The estimated annual burden hours are 2000, there 
are no costs to respondents other than their time.

[[Page 8646]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of     Average  burden
         Type of respondent                  Form name            Number of      responses per    per  response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation  DORI Data Collection              4,000                1            30/60
 Participants.                         Instruments.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-02550 Filed 2-5-21; 8:45 am]
BILLING CODE 4163-18-P